Feb 25 • 19:29 UTC 🇦🇷 Argentina Clarin (ES)

Why magnesium and potassium are the two key minerals to treat fatty liver

The article discusses the rising prevalence of non-alcoholic fatty liver disease and highlights the important roles of magnesium and potassium in its treatment.

Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent globally, closely linked to obesity, overweight, and type 2 diabetes. Contrary to common assumptions, the exact causes of this condition remain largely unknown; however, recent research emphasizes the therapeutic value of magnesium and potassium in managing the disease. In the United States, it is reported that one in four individuals are affected by NAFLD, which can lead to serious health complications such as cirrhosis or liver cancer if left untreated.

The condition is typically asymptomatic, but some individuals report signs such as severe fatigue or pain in the upper right abdomen. Early detection is essential to mitigate the risks of developing more severe complications. Healthcare professionals recommend that patients with fatty liver disease maintain a vigilant approach to monitor their health and consider dietary modifications focusing on nutrients like magnesium and potassium to help manage their condition effectively.

This article underscores the importance of understanding the nutritional aspects related to fatty liver disease, urging both patients and healthcare providers to recognize the potential benefits of minerals like magnesium and potassium as part of a comprehensive treatment strategy. As more people are impacted by obesity-related health issues, addressing these mineral deficiencies could be a pivotal step towards improving outcomes for those suffering from NAFLD.

📡 Similar Coverage